Molecular Tumor Board
After genomic test results were obtained, each case was discussed by the Molecular Tumor Board, which consisted of specialists such as medical oncologists, pathologists, radiologists, bioinformaticians, genetic counselors, clinical research coordinators, and treating physicians. These members discussed actionable genomic alterations and treatment options on the basis of the patient’s medical history, treatment history, family history, imaging findings, histopathological findings, and genetic test results (8).